Dr. Daniel Levy received his undergraduate degree from the University of Pennsylvania and his
medical degree from Boston University School of Medicine. He completed an internal medicine
residency at University Hospital in Boston and a cardiology fellowship at Brigham and Women's
Hospital and Harvard School of Public Health. Dr. Levy joined the Framingham Heart Study in
1984 and took over as Director after Dr. William P. Castelli retired in 1995. Dr. Levy has
published over 125 articles in leading medical journals. He is on the faculty of Harvard Medical
School and Boston University School of Medicine as Associate Professor of Medicine. In 1995
Dr. Levy was a recipient of the National Institutes of Health Director's Award for his research
achievements at the Framingham Heart Study.
Dr. Christopher O'Donnell received his undergraduate degree from Brown
University, his medical degree from Harvard Medical School, and his public
health degree from the Harvard School of Public Health. He completed an
internal medicine residency and cardiology fellowship at Massachusetts
General Hospital, as well as a cardiovascular epidemiology fellowship.
Thereafter, he continued on staff in the Department of Medicine (Cardiology
and Preventive Medicine) at the Brigham and Women's Hospital. In 1996, Dr.
O'Donnell joined the Framingham Heart Study as a Medical Officer of the
NHLBI. In 2002, he was appointed Associate Director of the Heart Study and
Co-Chair of its Genetic Steering Committee. He is director of cardiac CT
scanning and other subclinical imaging studies. His other research focus is
genetic epidemiology of clinical and subclinical cardiovascular disease.
Dr. O'Donnell has published over 75 peer reviewed articles and chapters.
He is also a staff cardiologist in the Department of Medicine,
Massachusetts General Hospital, and on the faculty of Harvard Medical
School. In 2000, Dr. O'Donnell was a recipient of the National Institutes
of Health Award of Merit for his research achievements at the Framingham
Dr. Philip A. Wolf received his medical degree from the State University of New York College
of Medicine at Syracuse, and completed his residency at the Massachusetts General Hospital in
Boston. He is Professor of Neurology and Research Professor of Medicine in epidemiology and
preventive medicine at Boston University School of Public Health, and Senior Visiting
Neurologist at Boston Medical Center where he is Director of the Cerebrovascular Disease
Section. He received a Jacob A. Javits Neuroscience Award from the National Institute of
Neurological Diseases and Stroke in 1992. The same year, he was also the first recipient of The
Humana Award for Excellence in Clinical Stroke of the Stroke Council of the American Heart
Association, and in 1996 he received the Mihara Award from the International Stroke Society.
Dr. Wolf has published on a wide range of neurology-related topics, primarily stroke, authoring
or co-authoring over 300 refereed articles, book chapters, and abstracts. His research has
appeared in such journals as The New England Journal of Medicine, Journal of
the American Medical Association, Neurology, Stroke, and
Journal of the American College of Cardiology. His numerous professional
association memberships include the American Neurologic Association, the American
Epidemiologic Society, the American Academy of Neurology, and the American Heart
Ralph B. D'Agostino, Sr., is a Professor of Mathematics/Statistics, Public Health and Law at
Boston University. His major fields of research are multivariate analysis, longitudinal studies,
epidemiology, clinical trials, and outcomes/effectiveness research. He is a fellow of the
American Statistical Association and the Cardiovascular Epidemiology section of the American
Heart Association and twice recipient of the Food and Drug Administration (FDA)
Commissioner's Special Citation (1981 and 1995). He has been affiliated with the Framingham
Heart Study since 1981 and is presently Co-Principal Investigator of the core NHLBI contract
and Director of Data Management and Analysis for the entire study. He has also been affiliated
with the FDA since 1974 as an expert consultant to the Biometrics Division of the Bureau of
Drugs, the Over-the-Counter Drug Division, the Cardiovascular-Renal Drugs Division, and the
Gastrointestinal Drugs Division. He has served on a number of FDA advisory committees and is
presently the Chair of the Nonprescriptive Drugs Advisory Committee. He is co-author/editor of
four books, on Factor Analysis, Goodness-of-Fit Techniques,
Mathematical Models in Health Services Research, and Engineering
Statistics. He has served on the editorial boards of the Journal of the American
Statistical Association, Biostatistica, and Statistics in Medicine.
He is presently the U.S. editor of Statistics in Medicine.
Dr. William B. Kannel is Professor of Medicine and Public Health at Boston University School
of Medicine and Director of the Visiting Scientist Program at the Framingham Heart Study. He
served as Director of the Framingham Heart Study from 1966 to 1979. Doctor Kannel received
his medical degree from the Medical College of Georgia and a master's degree in public health
from Harvard University. He is a board-certified cardiologist as well as a member of the
American College of Epidemiology. He is an author or co-author of close to 600 scientific
publications and is the recipient of many distinguished awards such as the Dana Award in
Preventive Medicine, the Einthoven Award, the Gairdner Award, the CIBA Award for
Hypertension Research, the James D. Bruce Memorial Award of the American College of
Physicians, the Charles A. Dana Award for Pioneering Achievement in Health, the Bristol-Myers
Squibb Award for Distinguished Achievement in Cardiovascular Research, and the
Distinguished Alumnus Award from the University of Georgia.
Director of the Echocardiography Laboratory, Co-Principal Investigator
Dr. Emelia J. Benjamin received her undergraduate degree from Harvard University, her medical
degree from Case Western Reserve University, and her master's degree in epidemiology from the
Harvard School of Public Health. Since 1990 she has directed the echocardiography laboratory at
the Framingham Heart Study, and since 1993 she has been Co-Principal Investigator of the
Framingham Heart Study. Since 1990 she has been Assistant Professor of Medicine at Boston
University, where she is on the attending staff as a clinical cardiologist. Dr. Benjamin serves as a
consultant to the NHLBI Atherosclerosis Risk in Communities echocardiography study on a
minority population in Jackson, Mississippi, and as a member of the Endpoints Committee for a
large Veterans Health Administration cooperative trial.
Dr. Joanne Murabito graduated from the University of Rochester in 1981 and received her
medical degree from Mount Sinai School of Medicine in New York in 1985. She completed a
residency in internal medicine at Boston University Hospital followed by a research fellowship at
the Framingham Heart Study and a master's degree in epidemiology at the Harvard School of
Public Health. Dr. Murabito is currently Director of the Clinic at the Framingham Heart Study
and Associate Director of the Preventive Medicine Residency at Boston University School of
Medicine. In addition, she is Assistant Professor of Medicine at Boston University School of
Medicine and practices primary care and women's health at Boston University Medical Center.